Seeking Alpha

Goldman recommends buying Allergan (AGN +0.2%) on its recent pullback, saying the company is...

Goldman recommends buying Allergan (AGN +0.2%) on its recent pullback, saying the company is well positioned with its diversified portfolio, emerging market exposure, and high growth potential. The firm reiterates its Buy rating with a $106 price target.
From other sites
Comments (1)
  • viper32nc1
    , contributor
    Comments (95) | Send Message
     
    If Goldman Sachs is telling you to buy it, it's because they are shorting it!
    25 May 2012, 10:39 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector